60 Degrees Pharmaceuticals SXTP
NASDAQ SXTP
$1.39 +0.14 (+11.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

60 Degrees Pharmaceuticals (SXTP) Non Operating Investment Income (2022 - 2023)

Updated

60 Degrees Pharmaceuticals' Non Operating Investment Income was -$20,008 in Q3 2023, compared with $75,904 a year earlier.

Analysis

60 Degrees Pharmaceuticals (SXTP) Non Operating Investment Income (2022 - 2023) Analysis & Trends

On a trailing twelve-month basis, 60 Degrees Pharmaceuticals' Non Operating Investment Income was -$110,496 through Sep 30, 2023.

  • Quarterly Non Operating Investment Income has moved between -$124,445 (Q2 2023) and $75,904 (Q3 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 60 Degrees Pharmaceuticals 3.70 Mn 2.59 Mn 56,798.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -20,008.00
Jun 30, 2023 -124,445.00
Sep 30, 2022 75,904.00
Jun 30, 2022 -41,947.00
API Access

60 Degrees Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=SXTP&period=max&api_key=YOUR_API_KEY